The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 28, 2021

Filed:

Oct. 04, 2019
Applicants:

Janssen Vaccines & Prevention B.v., Leiden, NL;

Beth Israel Deaconess Medical Center, Inc., Boston, MA (US);

Inventors:

Dan Barouch, Newton, MA (US);

Johanna Schuitemaker, Amstelveen, NL;

Maria Grazia Pau, Leiden, NL;

Danielle Van Manen, Leiden, NL;

Frank Tomaka, Titusville, NJ (US);

Jennifer Anne Hendriks, Poeldijk, NL;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/861 (2006.01); C12N 15/863 (2006.01); A61K 39/21 (2006.01); C07K 14/005 (2006.01); C12N 15/86 (2006.01); A61K 39/12 (2006.01); C12N 7/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/21 (2013.01); A61K 39/12 (2013.01); C07K 14/005 (2013.01); C12N 7/00 (2013.01); C12N 15/86 (2013.01); A61K 2039/55505 (2013.01); A61K 2039/575 (2013.01); C12N 2710/10043 (2013.01); C12N 2710/24143 (2013.01); C12N 2740/16034 (2013.01);
Abstract

Compositions, vaccines and methods for inducing an immunity, including a protective immunity, against Human Immunodeficiency Virus (HIV) infection are described. Heterologous vaccine combinations of one or more adenovirus 26 vectors using for priming immunization and an isolated HIV antigenic polypeptide in combination with one or more MVA vectors for boosting immunization induced strong protective immunity against infections by one or multiple clades of HIV.


Find Patent Forward Citations

Loading…